What is the primary mechanism of proton pump inhibitors and a potential long-term risk?

• A. They increase bicarbonate production in the stomach
• B. They neutralize acid directly in the lumen
• C. They block histamine receptors in the stomach
• D. They irreversibly inhibit the gastric parietal cell H+/K+ ATPase and long-term use is associated with increased risk of C. difficile infection and osteoporosis

Answer: (D)

Proton pump inhibitors work by targeting the final step of acid secretion in the stomach: the H+/K+ ATPase (the proton pump) on gastric parietal cells. They are prodrugs that become active in the acidic canaliculi of these cells and form a covalent, irreversible bond with the pump, effectively blocking proton (H+) secretion into the stomach lumen. Because the inhibition is irreversible, the effect lasts until new pumps are synthesized, so acid production remains suppressed for a longer period even after the drug itself is cleared.

This deep and sustained acid suppression can have downstream risks with long-term use. A less acidic stomach environment can predispose to enteric infections such as Clostridioides difficile, since the acidic barrier to ingested organisms is reduced. It can also interfere with calcium and nutrient absorption, contributing to osteoporosis risk over time, among other potential deficiencies like vitamin B12 and magnesium.

For contrast, remember that neutralizing acid directly in the lumen is what antacids do, not PPIs. Blocking histamine receptors in the stomach is the action of H2 receptor antagonists, not PPIs. And PPIs do not increase bicarbonate production; their role is to suppress acid production by inhibiting the proton pump.